skip to main content
back

Press Releases

29 Apr 2004

United Therapeutics To Announce First Quarter 2004 Financial Results Before Market Open On May 6, 2004
Download pdf

31 Mar 2004

FDA Accepts United Therapeutics' Intravenous Remodulin® SNDA Filing For Review
Download pdf

15 Mar 2004

United Therapeutics Announces Adoption of 10b5-1 Trading Plans
Download pdf

10 Mar 2004

Remodulin® European Long-Term Data Presented at American College of Cardiology Conference
Download pdf

24 Feb 2004

United Therapeutics Reports 2003 Annual Financial Results
Download pdf

05 Feb 2004

OVAREX Updated Phase II Trial Results to be Presented at Plenary Session of the Society of Gynecological Oncology
Download pdf

02 Feb 2004

United Therapeutics Announces Filing of Supplemental New Drug Application for Intravenous Remodulin®
Download pdf

26 Jan 2004

United Therapeutics Announces Bioequivalence of Subcutaneously and Intravenously Delivered Remodulin and Fourth Quarter Remodulin Patient Results
Download pdf

06 Jan 2004

United Therapeutics Receives Supplemental Information Request from French Agency
Download pdf

17 Dec 2003

United Therapeutics Receives Preliminary Notice of Approval for Remodulin in Switzerland and Australia
Download pdf

11 Nov 2003

Roger Jeffs, Ph.D. Adopts 10b5-1 Trading Plan
Download pdf

11 Nov 2003

United Therapeutics Granted Additional Arginine Supplementation Patent Over Prior Art
Download pdf

(Showing 433 – 444 of 513)